Biora Therapeutics, Inc. Common Stock
BIOR
BIOR was delisted on the 10th of December, 2024.
27 hedge funds and large institutions have $84.5M invested in Biora Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$71.2M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$4.71M |
| 3 |
FAM
Fred Alger Management
New York
|
+$4.54M |
| 4 |
RI
RTW Investments
New York
|
+$3M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$2.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$2.72K | +1 | New |
|
27
US Bancorp
Minneapolis,
Minnesota
| $2K | +$2.72K | +1 | New |
|
BIOR Hedge Fund Activity: Q2 2020 in Review
27 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Biora Therapeutics, Inc. Common Stock (BIOR) for Q2 2020, worth a combined $84.5M.
Buyers outnumbered sellers: 27 funds opened new BIOR positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Neuberger Berman Group, opening a new position worth an estimated $71.2M.
- 27 institutional investors held Biora Therapeutics, Inc. Common Stock (BIOR) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $84.5M of Biora Therapeutics, Inc. Common Stock stock for Q2 2020.
- 27 funds opened new Biora Therapeutics, Inc. Common Stock positions in Q2 2020 and 0 closed out, a net change of +27 holders.
- The largest Biora Therapeutics, Inc. Common Stock buyer in Q2 2020 was Neuberger Berman Group, an estimated $71.2M added.
Based on aggregated 13F filings for Q2 2020.